Method of detecting cyclooxygenase-2
AssigneeG.D. Searle & Co.
InventorsPeter C. Isakson, Karen Seibert, John J. Talley
Life of this patent
Estimating the term…
Abstract
The invention relates to a method of detecting concentrations of cyclooxygenase-2 in a mammal, the method comprising: administering to the mammal a diagnostically effective amount of a cyclooxygenase-2 selective agent, which is capable of being detected in vivo; and b) detecting the agent so the concentration of cyclooxygenase-2 is detected.
Claims26
A method of detecting a concentration of cyclooxygenase-2 in a mammal, the method comprising:
- a) administering to the mammal a diagnostically effective amount of a cyclooxygenase-2 selective agent, which is capable of being detected in vivo;
- and
- b) detecting the agent so the concentration of cyclooxygenase-2 is detected.
A method of localizing and quantifying cyclooxygenase-2 in a mammal, said method comprising
- a) preparing a labeled compound, which selectively binds to cyclooxygenase-2 and which contains an isotope capable of emitting radiation;
- b) administering to said mammal a diagnostically effective amount of the labeled compound;
- and
- c) detecting an emission from the compound administered to the mammal so that the cyclooxygenase-2 in the mammal is localized.
A method of preparing a labeled cyclooxygenase-2 inhibitor, said method comprising halide exchange of a nitro radical or alkylation of alcohols
A method of detecting neoplasia in a mammal, said method comprising a) preparing a compound which selectively binds to cyclooxygenase-2 and which is labeled with an isotope capable of emitting gamma or positron radiation b) administering to said mammal a diagnostically effective amount of the labeled compound;
- and c) detecting an emission from the compound administered to the mammal so that the neoplasia in the mammal is localized.
A method of localizing and quantifying cyclooxygenase-2 in a mammal, the method comprising:
- a) preparing a compound which selectively binds to cyclooxygenase-2 and which is labeled with an isotope capable of emitting gamma radiation;
- b) administering to said mammal a diagnostically effective amount of the labeled compound;
- and
- c) detecting the gamma emission from the compound administered to the mammal so that the cyclooxygenase-2 in the mammal is localized.
A pharmaceutical composition for detecting a concentration of cyclooxygenase-2 comprising a pharmaceutically-acceptable carrier and optimally, at least one pharmaceutically-acceptable adjuvant;
- and an active substance comprising a diagnostically-effective amount of a compound which is capable of being detected in vivo.
A pharmaceutical composition for detecting a concentration of cyclooxygenase-2 comprising a pharmaceutically-acceptable carrier and optimally, at least one pharmaceutically-acceptable adjuvant;
- and an active substance comprising a diagnostically-effective amount of a compound which is labeled with an isotope capable of emitting gamma or positron radiation.
Dependencies are inferred from the claim text.